Tarsus Pharmaceuticals, Inc. upgraded to Strong Buy; Xdemvy's rapid US growth and unique market lead highlight big upside.

Mizuho initiated coverage of Tarsus Pharmaceuticals (TARS) with an Outperform rating and $100 price target Tarsus is a commercial stage, ...

During the week, Bryan Wahl is the full-time general counsel for Tarsus Pharmaceuticals, one of Orange County’s standout ...

A new treatment is presented that eliminates the root cause of the disease and restores ocular surface health.

A severe case of misdiagnosis is revisited to show how careful evaluation led to recovery and renewed patient trust.

Delivered quarterly XDEMVY ® net sales of approximately $119 million, up approximately 147% year-over-year Weekly multi-patient prescribers grew approximately 30% in the third quarter underscoring ...

Dear Doctors: I am a 29-year-old woman, and I am concerned that I might have mites in my areola. I found one when I tried to squeeze what I thought was a whitehead and saw a demodex mite come out. I ...

Xdemvy (lotilaner ophthalmic solution) is a brand-name prescription eye drop used in adults to treat blepharitis (eyelid inflammation) caused by Demodex mites. As with other drugs, Xdemvy can cause ...

The dosage of Xdemvy (lotilaner ophthalmic solution) for Demodex blepharitis is typically 1 drop per eye twice daily for 6 weeks. It’s important to take the Xdemvy dosage your doctor prescribes.

With an irresistible earworm and a remarkably well-integrated plan, Miebo Ohh Yeah succeeded against some remarkable odds. The product, a prescription treatment for dry eye, had to clear some ...

Xdemvy is an eye drop prescribed for adults to treat Demodex blepharitis, an eyelid condition caused by mites. The recommended dosage is 1 drop in each eye twice per day for 6 weeks. While some people ...

Combined light therapy with intense pulsed light (IPL) and low-level light therapy (LLLT) using blue and red lights decreased mite counts and improved ocular surface parameters and symptoms in ...